MIDODRINE HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for midodrine hydrochloride and what is the scope of patent protection?
Midodrine hydrochloride
is the generic ingredient in three branded drugs marketed by Alembic, Apotex, Aurobindo Pharma Ltd, Chartwell Rx, Endo Operations, Impax Pharms, Mankind Pharma, Mylan Pharms Inc, Novugen, Rubicon, Thinq Pharm-cro Pvt, Xiromed, Zydus Lifesciences, Upsher Smith Labs, and Takeda Pharms Usa, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.There are thirteen drug master file entries for midodrine hydrochloride. Twenty-eight suppliers are listed for this compound.
Summary for MIDODRINE HYDROCHLORIDE
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 15 |
NDAs: | 15 |
Drug Master File Entries: | 13 |
Finished Product Suppliers / Packagers: | 28 |
Raw Ingredient (Bulk) Api Vendors: | 87 |
Clinical Trials: | 100 |
Patent Applications: | 391 |
What excipients (inactive ingredients) are in MIDODRINE HYDROCHLORIDE? | MIDODRINE HYDROCHLORIDE excipients list |
DailyMed Link: | MIDODRINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for MIDODRINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Noha Mansour | Phase 4 |
Yeditepe University Hospital | N/A |
Henan Provincial People's Hospital | N/A |
Pharmacology for MIDODRINE HYDROCHLORIDE
Drug Class | alpha-Adrenergic Agonist |
Mechanism of Action | Adrenergic alpha-Agonists |
Medical Subject Heading (MeSH) Categories for MIDODRINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for MIDODRINE HYDROCHLORIDE
US Patents and Regulatory Information for MIDODRINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chartwell Rx | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 076514-002 | Sep 11, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Zydus Lifesciences | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 213055-002 | Sep 1, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Rubicon | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 212543-002 | Aug 19, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Rubicon | MIDODRINE HYDROCHLORIDE | midodrine hydrochloride | TABLET;ORAL | 212543-001 | Aug 19, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.